Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility.
Saved in:
| Title: | Methylated DNA markers for plasma detection of ovarian cancer: Discovery, validation, and clinical feasibility. |
|---|---|
| Authors: | Marinelli LM; Department of Pathology and Area Laboratory Services, San Antonio Military Medical Center, San Antonio, TX, United States of America., Kisiel JB; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America., Slettedahl SW; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, United States of America., Mahoney DW; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, United States of America., Lemens MA; Obstetrics and Gynecology, Division of Gynecologic Oncology Surgery, Mayo Clinic, Rochester, MN, United States of America., Shridhar V; Department of Laboratory Medicine and Pathology, Experimental Pathology, Mayo Clinic, Rochester, MN, United States of America., Taylor WR; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America., Staub JK; Department of Laboratory Medicine and Pathology, Experimental Pathology, Mayo Clinic, Rochester, MN, United States of America., Cao X; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America., Foote PH; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America., Burger KN; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, MN, United States of America., Berger CK; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America., O'Connell MC; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America., Doering KA; Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, United States of America., Giakoumopoulos M; Exact Sciences, Madison, WI, United States of America., Berg H; Exact Sciences, Madison, WI, United States of America., Volkmann C; Exact Sciences, Madison, WI, United States of America., Solsrud A; Exact Sciences, Madison, WI, United States of America., Allawi HT; Exact Sciences, Madison, WI, United States of America., Kaiser M; Exact Sciences, Madison, WI, United States of America., Vaccaro AM; Exact Sciences, Madison, WI, United States of America., Albright Crawford C; Exact Sciences, Madison, WI, United States of America., Moehlenkamp C; Exact Sciences, Madison, WI, United States of America., Shea G; Exact Sciences, Madison, WI, United States of America., Deist MS; Exact Sciences, Madison, WI, United States of America., Schoolmeester JK; Department of Laboratory Medicine and Pathology, Anatomic Pathology, Mayo Clinic, Rochester, MN, United States of America., Kerr SE; Hospital Pathology Associates, Minneapolis, MN, United States of America., Sherman ME; Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida, United States of America., Bakkum-Gamez JN; Obstetrics and Gynecology, Division of Gynecologic Oncology Surgery, Mayo Clinic, Rochester, MN, United States of America. Electronic address: bakkum.jamie@mayo.edu. |
| Source: | Gynecologic oncology [Gynecol Oncol] 2022 Jun; Vol. 165 (3), pp. 568-576. Date of Electronic Publication: 2022 Mar 31. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
